Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 639 of 6351
-
New drug combo aims to boost weight loss in obesity trial
Disease control OngoingThe main aim of the study is to assess the effect of RO7204239 in combination with tirzepatide, compared to placebo in combination with tirzepatide, on body weight loss after 48 weeks of treatment in adults with obesity or overweight with at least one weight-related comorbidity, …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 10, 2026 07:00 UTC
-
New drug cocktails aim to stop bile duct cancer return after surgery
Disease control Recruiting nowThis multicenter real-world study assesses the efficacy and safety of adjuvant therapies in postoperative intrahepatic cholangiocarcinoma (ICC) patients with high-risk recurrence factors. 90 eligible patients will be assigned to: Cohort 1: GP (gemcitabine/cisplatin) + adebrelima…
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug duo aims to shrink tough lung cancers
Disease control Recruiting nowThis study aims to investigate the combination of BNT324, a B7-H3 antibody-drug conjugate (ADC) with BNT327, a programmed death-ligand 1 (PD-L1) and vascular endothelial growth factor (VEGF) bispecific antibody, in participants with advanced/metastatic or relapsed/progressive sma…
Phase 1/2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Experimental drug combo aims to tackle tough lymphoma
Disease control Recruiting nowThis is an open-label, phase I/II study of duvelisib in combination with Venetoclax for patients with relapsed/refractory NHL. Duvelisib is an FDA approved, marketed product used to treat certain patients with leukemia and lymphoma and Venetoclax, which is approved for treatment …
Phase 1/2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can hidden malaria reservoirs be unmasked?
Knowledge-focused Recruiting nowThe goal of this prospective cohort study is to understand the factors responsible for the persistence of malaria transmission in some areas despite intensive control efforts. The study will measure the prevalence and incidence of asymptomatic and sub-patent Plasmodium infections…
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New drug cocktail targets myeloma tumors outside the bone marrow
Disease control Recruiting nowThis phase II trial studies how well mezigdomide/carfilzomib/dexamethasone (MeziKD) works in treating patients with multiple myeloma (MM) that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory) and have tumors from myeloma ce…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Immunotherapy combo shows promise in Hard-to-Treat rectal cancer
Disease control Recruiting nowSafety and efficacy of Short-Course Radiotherapy Followed by Sequential Chemotherapy with or without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer. Complete Response (CR) Rate of Short-Course Radiotherapy Followe…
Phase 2 • Sponsor: Dechang Diao • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New combo therapy aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis study evaluates hypofractionated radiotherapy combined with PD-1 inhibitor-based systemic therapy in patients with metastatic solid tumors. Eligible patients will be enrolled into three cohorts according to tumor type: metastatic hepatocellular carcinoma, metastatic renal ce…
Sponsor: Zhen Zhang • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Game on for life: app fights suicide in mental health patients
Disease control Recruiting nowPatients with mental disorders are at significantly higher risk of suicide after discharge compared to the general population and patients with other diseases. Currently, there is a lack of post-discharge community suicide risk management services in China. The research team's pr…
Sponsor: Shenzhen Kangning Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Blood test may spot hidden heart killer
Diagnosis Recruiting nowShort-coupled ventricular fibrillation (SCVF) is a lethal, primary electrical disorder and an important cause of unexplained cardiac arrest.1 Recent work from our group suggests that a substantial proportion of SCVF cases is associated to circulating autoantibodies targeting TREK…
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Engineered t cells take on ovarian cancer in new trial
Disease control Stopped earlyThe primary objectives are to evaluate the safety and efficacy of infusion of autologous ovarian cancer immunogene-modified T cells (OC-IgT cells).
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Robotic glove may help stroke survivors regain hand control
Disease control CompletedStroke is a neurological deficit attributed to an acute focal injury of the central nervous system. A key component of stroke rehabilitation is improving upper limb function to reduce impairments and disabilities. A task-specific approach retraining for upper extremity control se…
Sponsor: Adly A Adam • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could shedding pounds be the key to silencing chronic back pain?
Symptom relief Recruiting nowWe will recruit overweight/ obese participants between the age of 18 and 65 with chronic nonspecific low back pain . The participants will be randomly assigned to one of two interventions (each lasting 10 weeks). All interventions will be delivered in a blended format and will be…
Sponsor: Vrije Universiteit Brussel • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Bollywood dance and fitness trackers: a new weapon against breast cancer?
Prevention OngoingThis study aims to to improve physical activity and metabolic outcomes for breast cancer prevention in South Asian Indian immigrant women.
Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Family support may be key to easing lung cancer surgery stress
Symptom relief CompletedTo clarify the irrational cognition of family caregivers of lung cancer patients at various perioperative stages under the background of protective medical treatment, construct an indirect intervention model for lung cancer patients, and evaluate its clinical efficacy. To develo…
Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Can a smarter needle catch more prostate cancers?
Diagnosis Recruiting nowTo study a novel biopsy needle system for performing transperineal prostate biopsy. Prostate biopsy remains the standard approach for prostate cancer detection. While pre-biopsy MRI allows for targeting of visible lesions, systemic or 'off target' samples are recommended due to t…
Sponsor: University of California, Davis • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
A radioactive 'Iron Magnet' could reveal hidden lung fungus
Diagnosis CompletedThis is a single center open-label feasibility trial involving a single study visit for participants. The purpose of the study is to demonstrate the feasibility of \[68Ga\]Ga-DFO-B PET/CT (gallium-68-deferoxamine) for the visualization of pulmonary Aspergillus infection. The inc…
Phase 2 • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
A tailored diet may lower heart risk in kidney failure
Disease control OngoingIn patients with kidney failure, disturbances in bone turnover, mineral metabolism, vascular calcification, uremia, inflammation, immunity, metabolomics, nutrition, and gut microbial metabolites are frequent. Unhealthy diet causes altered mineral metabolism, elevated uremic toxin…
Sponsor: Far Eastern Memorial Hospital • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug lorigerlimab takes on Platinum-Resistant ovarian cancer
Disease control Recruiting nowStudy CP-MGD019-03 is an open-label study of lorigerlimab in participants with platinum-resistant ovarian cancer (PROC) or clear cell gynecologic cancer (CCGC). Approximately 80 participants will be enrolled. The study will assess the efficacy and safety of lorigerlimab in partic…
Phase 2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a diabetes drug help teens with rare obesity syndromes shed pounds?
Disease control Recruiting nowThis research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalamic obesity, as compared to young adults with obesity that is unrelated to a genetic syndrome or underlying medical cause. …
Phase 4 • Sponsor: Grace Kim • Aim: Disease control
Last updated Jun 26, 2026 17:35 UTC